British American Tobacco Faces Triple Threat: EU Regulation, Illegal Trade, and a Technical Sell-Off

British American Tobacco’s stock sold off sharply last week even as Barclays lifted its price target, underscoring the complex set of pressures facing the cigarette giant. The shares closed Friday at €52.66, a decline of 6.37% over the five?day period, with four consecutive losing days. Despite the weekly rout, the longer?term picture remains positive: the stock is up 9.37% year?to?date and 33.15% over the past twelve months, still only 7.90% below the 52?week high of €57.18 set on 18 May.

The sell?off gathered pace through the week. From €55.29 on Tuesday, the price slipped to €54.74 on Wednesday and €53.99 on Thursday before closing at Friday’s low. Trading volume exploded to 14.69 million shares on Friday, compared with just 2.12 million the previous day and 4.90 million on Wednesday, suggesting a wave of profit?taking rather than a fundamental shock.

Across the Atlantic, the company stepped up its lobbying efforts as the European Union prepares to review its Tobacco Products Directive. BAT launched the “Share Your Voice” campaign, mobilising consumers and trade partners to participate in the EU consultation. The move follows an evaluation report published by the European Commission in April 2026 that, according to BAT, points toward stricter rules or even a ban on certain smoke?free products. The company argues that more than 30 million European adults have already switched from cigarettes to reduced?risk alternatives and should have a say in the process. Crucially, the Commission’s own regulatory scrutiny committee voted down the evaluation report late last year, criticising it for failing to attribute specific effects to individual measures. BAT is using that rebuke to warn that the EU risks undermining its own goal of a smoke?free society by 2040.

Should investors sell immediately? Or is it worth buying British American Tobacco?

Meanwhile, in Latin America, the illegal cigarette trade is eating into legitimate market share. Recent data from Chile shows that roughly 60% of cigarettes consumed there now come from the black market, directly squeezing volumes and margins. BAT has already closed offices in Ecuador and Bolivia in response to similar smuggling dynamics, with the port of Antofagasta identified as a key entry point for contraband. The Latin American headwinds helped erase gains from a sharp rally in early May. On 12 May, the London?listed shares jumped nearly 6% to £46.34 after the US Food and Drug Administration signalled it would temporarily hold off enforcement actions against certain unauthorised e?cigarettes and nicotine pouches with pending applications, a move that benefited BAT’s Vuse and Velo brands.

Despite the headwinds, BAT’s underlying business delivered solid momentum in the first quarter. Revenue from non?combustible products rose 17% on a constant?currency basis. Vuse vaping products posted volume growth of 12%, while Velo nicotine pouches surged 28%. The company reaffirmed its full?year targets of 3%–5% constant?currency revenue growth and leverage reduction to 2.0–2.5 times, alongside a multibillion?pound share buyback programme. A management change is also on the horizon: Dragos Constantinescu will assume the role of chief financial officer on 1 September, taking the helm of the finance function as BAT navigates regulatory scrutiny on both sides of the Atlantic. The next major catalyst comes on Tuesday, 2 June, when BAT publishes its half?year trading update at 7:00 a.m. British time, followed by a webcast at 8:30 a.m. Investors will be looking for signs of pricing power, cash flow generation, and progress in the smokeless transition. In a small but visible signal of alignment, CEO Tadeu Marroco purchased 173 shares through a dividend reinvestment plan last week at a price of £43.72 each, for a total of £7,563.

Technically, the shares are approaching a key support zone between €50.89 and €51.64, an area reinforced by several trendlines and the 50?day moving average at €51.38. A breakdown below that band would deepen the correction, while a bounce could pave the way for a recovery. On the upside, the all?time high of €57.18 and further resistance at €57.48 remain the immediate hurdles. The average analyst price target stands at 5,045 pence, with eight of nine analysts recommending a buy. Barclays, which raised its target to 5,400 pence from 4,900 pence and reiterated an “overweight” rating, sees the current weakness as an entry point rather than a reason to flee. The half?year numbers will test that conviction.

Ad

British American Tobacco Stock: New Analysis - 30 May

Fresh British American Tobacco information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated British American Tobacco analysis...

en | GB0002875804 | BRITISH | boerse | 69449509 |